Rosacea vs. Seborrheic Dermatitis: How to Tell Them Apart

Why These Two Conditions Are Frequently Confused

Rosacea and seborrheic dermatitis share enough surface features to confuse patients and, occasionally, clinicians: both produce facial redness, both affect adults, both are chronic and relapsing, and both become more visible in winter or with certain environmental exposures. In practice, however, they are distinct conditions with entirely different underlying biology, different treatment strategies, and different long-term implications.

Distinguishing them matters because treating seborrheic dermatitis like rosacea (or vice versa) delays effective management. Using antifungal agents on rosacea does nothing. Using AHAs or harsh cleansers to address what appears to be greasy skin can trigger a severe rosacea flare. And when both conditions coexist — which they can — a combined treatment plan is needed.

Side-by-Side Comparison

Detailed Clinical Features of Each Condition

Rosacea

Rosacea is a chronic inflammatory condition of the central face driven by dysregulated innate immunity (TLR2/KLK5/LL-37 signaling), Demodex mite overgrowth, and neurovascular hyperreactivity. It presents in four overlapping subtypes — erythematotelangiectatic, papulopustular, phymatous, and ocular — but all share the hallmark of persistent erythema of the convex facial surfaces.

Characteristic features:

• Flushing — episodic, triggered by heat, alcohol, stress, spicy food, exercise, and emotional stimuli; can last minutes to hours
• Persistent background erythema — does not fully resolve between flares; worsens over years without treatment
• Telangiectasia — visible dilated blood vessels, particularly on the nose and cheeks; irreversible once established
• Papules and pustules — in papulopustular rosacea; resemble acne but lack comedones
• Burning and stinging — a neurogenic feature; many patients report that the skin "feels hot" even when not visibly flushed
• Sensitivity — nearly all rosacea products trigger reactions in a significant proportion of patients; alcohol and fragrance are the most consistent irritants

What rosacea does NOT produce: Scales, greasy skin, scalp involvement, nasolabial fold distribution.

Seborrheic Dermatitis

Seborrheic dermatitis (SD) is a common, chronic, relapsing form of dermatitis caused by the inflammatory response to Malassezia yeast — a lipophilic fungus that is normal skin flora but overgrows in sebaceous-rich areas. The condition affects areas with high sebum production, and Malassezia lipases cleave free fatty acids from sebum triglycerides in a way that triggers the inflammatory cascade.

Characteristic features:

• Greasy, yellowish scales — the pathognomonic feature; scale color distinguishes it from psoriasis (silver-white) and rosacea (absent)
• Distribution in sebaceous-rich zones — nasolabial folds, eyebrows, glabella, beard area, ear canals, scalp, central chest, skin folds
• Scalp involvement — SD on the scalp manifests as dandruff; in severe cases, well-demarcated scaly plaques on the scalp
• Blepharitis — scaly, red eyelid margins; may cause mild eye irritation
• Variable redness — from mild pinkish to salmon-colored patches; redness is secondary to scale rather than primary
• Seasonal pattern — typically worse in winter and improves with summer UV exposure (the opposite of rosacea)
• Itching — typically mild or absent, in contrast to eczema

What SD does NOT produce: Flushing, visible blood vessels (telangiectasia), skin thickening, or eye gritiness from ocular involvement.

The Key Distinguishing Questions

When trying to determine which condition is present (or if both are), these clinical questions are the most diagnostically useful:

1. Do you flush? Episodic flushing — triggered by heat, alcohol, spicy food, or exercise — is a rosacea feature. Seborrheic dermatitis does not cause flushing.

2. Is scaling present? Any greasy, yellowish scaling points immediately to seborrheic dermatitis. Rosacea does not produce scales.

3. Where exactly is the redness? Rosacea is centered on convex surfaces: the nose, cheeks, and forehead. Seborrheic dermatitis favors concave areas and folds: the creases beside the nose, eyebrows, behind the ears. If redness is in the nasolabial folds, think seborrheic dermatitis first. If it is on the nose and cheek convexities, think rosacea.

4. Is your scalp affected? Flakiness, itching, or scaling on the scalp alongside facial symptoms is strong evidence for seborrheic dermatitis (dandruff = SD on the scalp). Rosacea rarely affects the scalp.

5. Does sun exposure help or worsen it? Rosacea is consistently worsened by sun exposure (81% of patients). Seborrheic dermatitis often improves in summer with UV exposure (UV has mild antifungal properties). A patient who says "my skin gets worse in summer" is likely describing rosacea.

6. Do antifungal products help? If an antifungal shampoo (ketoconazole 2%) used as a face wash produces noticeable improvement, the diagnosis is almost certainly seborrheic dermatitis or a seborrheic component. Antifungals have no specific effect on rosacea's core pathology.

Dermoscopic Differentiation

When clinical assessment is ambiguous, dermoscopy provides additional objective information. A 2020 study published in PMC identified the following dermoscopic signatures:

The arborizing vessel pattern in rosacea corresponds histologically to the extensive telangiectasias in the superficial and middle dermis. The dotted and curved vessels of seborrheic dermatitis reflect dilated papillary dermal vessels within psoriasiform hyperplasia.

Can Both Be Present at the Same Time?

Yes. Rosacea and seborrheic dermatitis are confirmed comorbidities. A 2025 retrospective cohort study found that rosacea patients have a significantly increased risk of seborrheic dermatitis compared to the general population. The facial overlap is particularly challenging: central facial redness with nasolabial fold involvement and some scaling may represent mixed disease.

When both are present, treatment must address both conditions simultaneously. Using only rosacea treatment leaves seborrheic dermatitis active (scaling, yeast overgrowth continues). Using only antifungals leaves the neurovascular and innate immune drivers of rosacea unaddressed.

Treatment Differences

For Rosacea

• Daily mineral SPF 30+ sunscreen; trigger avoidance; gentle barrier-repair skincare
• Topical: azelaic acid 15% gel, metronidazole 0.75%/1%, ivermectin 1% cream
• Oral: low-dose doxycycline (40 mg modified-release) for moderate-to-severe disease
• Procedural: pulsed dye laser, IPL for telangiectasia and persistent erythema

See Rosacea guide and Rosacea skincare routine for the full treatment ladder.

For Seborrheic Dermatitis

Topical antifungals (first-line):

• Ketoconazole 2% shampoo or cream — applied to affected areas for 5 minutes then rinsed, 2–3 times weekly; for facial SD, diluted or brief-contact application to affected areas
• Ciclopirox 1% cream or gel — twice daily to affected non-scalp areas
• Selenium sulfide 2.5% shampoo — effective on scalp, not for facial use

Anti-inflammatory adjuncts:

• Mild topical corticosteroids (1% hydrocortisone cream) — short-term (1–2 weeks) for acute flares; prolonged use on the face causes atrophy and can cause or worsen rosacea
• Topical calcineurin inhibitors (tacrolimus, pimecrolimus) — effective for long-term maintenance when repeated steroid courses are needed; preferred over steroids for facial use

Skincare:

• Minimize emollients (Malassezia is lipophilic — heavy creams can feed the yeast)
• Use non-soap cleansers or ketoconazole shampoo as a face wash during flares
• Keratolytic cleansers (salicylic acid) to manage scale

When a Diagnosis Is Uncertain

If the clinical picture is ambiguous after careful assessment, a dermatologist may:

• Perform dermoscopy to visualize vascular patterns
• Conduct a potassium hydroxide (KOH) preparation of skin scraping — Malassezia hyphae visible under microscopy support SD (though Malassezia is normal flora and its mere presence is not diagnostic)
• Take a punch biopsy — histology showing parakeratosis, follicular plugging, and spongiosis supports SD; extensive dermal telangiectasia and perivascular mononuclear infiltrate support rosacea
• Conduct a therapeutic trial — ketoconazole 2% for 4 weeks as a test; improvement confirms a seborrheic dermatitis component

Do not self-diagnose ambiguous facial skin conditions. The treatments for each condition differ significantly, and using the wrong treatment can worsen the other condition.